Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gaston JSH et al. – Clinical trials of candidate Shigella vaccines should be pursued aggressively in the developing world, beginning with a Phase 1 in HLA B27–negative volunteers, but proceeding to Phase 2 and Phase 3 in unscreened volunteers. Post–vaccination monitoring for possible reactive arthritis should be included in all clinical protocols.

Related Articles

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09    Relevance Score: 99%

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09    Relevance Score: 97%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09    Relevance Score: 97%

Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09    Relevance Score: 96%

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09    Relevance Score: 95%

Today in Peds Allergy/Immunology...keeping you current

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09

Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans
Journal of Allergy and Clinical Immunology, 11/25/09

Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants: A Randomized Double-Blind Placebo-Controlled Study
The Pediatric Infectious Disease Journal, 11/25/09

Today in Rheumatic/Autoimmune...keeping you current

Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09

Adalimumab for the treatment of psoriatic arthritis
Expert Review of Clinical Immunology, 11/19/09

Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
BMC Musculoskeletal Disorders, 11/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address